Citeline, Sitetrove: 治験責任医師と治験施設情報のデータベース, Tr...

Citeline: Global Clinical Trial Intelligence Solutions

12 Mar 2019

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Sitetrove: 治験責任医師と治験施設情報のデータベース

Sitetrove Roundup Issue 6 - 2018 - Infographic

07 Jan 2019

Find the right investigators and sites for your clinical trials. For the pharma industry’s most accurate and comprehensive investigator and site intelligence, turn to the invaluable data in Sitetrove. Sitetrove’s team of expert analysts continuously scour over 43,000 public sources to update curated information on the global clinical trial landscape, with content tailored to specific therapeutic areas. Save time and avoid costly delays: find the right investigators in the geographic areas that suit your needs with Sitetrove.

Clinical Trials Industry Report

By KNect365 28 Aug 2018

Clinical trials are continually evolving, particularly in light of increasing pressures from new technologies and other disruptors. Trends ranging from artificial intelligence (AI) and mHealth to patient-centricity are challenging the industry to innovate against the backdrop of looming regulatory changes and shifting competitor landscapes resulting from M&A activity. In order to explore these trends, KNect365 Life Sciences recently conducted one of the biggest surveys of its kind across clinical trial professionals from within pharma, CROs, sites, service providers, academia and patient groups across the world to look beyond the hype.

Pharmaprojects, Biomedtracker, Trialtrove

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

By Rachel Meighan-Mantha 22 Mar 2017

The field of epigenetics is rapidly expanding and as interest continues to grow, epigenetics has become an increasingly promising area for research.

Pink Sheet：世界の薬事規制と承認審査に関するニュース

AstraZeneca Mulls Broad Ovarian Cancer Maintenance Approval For Lynparza

By Emily Hayes 15 Mar 2017

Discussion with regulators on conditional regulatory pathways will now begin after strong and durable immune responses against the Zaire Ebola virus were reported in a UK-based Phase I trial in healthy volunteers usingthefiloviruses vaccine Ad26.ZEBOV developed by Bavarian Nordic AS and licensed by Johnson & Johnson'sJanssen Pharmaceutical Cos.

Medtrack

Partnering in the Pharma world: BIO-Europe® and industry trends 2012-2015

By Patricia Giglio 14 Nov 2016

Partnering came into use twenty-odd years ago when pharmaceutical companies began working with biotech and increasingly sought external discovery and development opportunities.

Scrip：世界の医薬品産業ニュースサービス

From Solanezumab To Solithromycin: What To Watch For In Q4

11 Oct 2016

Lilly’s solanezumab, Roche/Genentech’s Ocrevus and Cempra’s solithromycin are among the key therapies scheduled for major data read-outs or approval decisions in Q4 2016.

Biomedtracker

Healthcare Conference BioMedTracker - Day 1

11 Aug 2016

The 34th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 11- 14, 2016